Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · N970003/S311

ALTRUA 2 (Model S722); ESSENTIO (Model L121); PROPONENT (Model L221); ACCOLADE (Model L321); ALTRUA 2 (Models S701,

Boston Scientific Corp · Decision date Oct 3, 2026

MEDTECHLEDGER EXPLANATIONN970003/S311

What did the FDA decide?

The FDA database entry for PMA number N970003, supplement S311, dated 2026-10-03, is a 30-Day Notice filed by Boston Scientific Corp under supplement reason 'Process Change - Manufacturer/Sterilizer/Packager/Supplier.' The listed device category is implantable pulse generator, pacemaker (non-CRT), specialty Cardiovascular, product code LWP. The source statement of purpose says the applicant intends 'to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification.' The specific acceptance activity, the changed specification, and the technical reasoning are not stated in the supplied fields.

The S311 supplement attaches to the existing N970003 approval, not a new approval of a whole pacemaker system. The manufacturer also lists ALTRUA 2, ESSENTIO, PROPONENT and ACCOLADE models for the family, yet the stated scope concerns only Accolade SL and Accolade EL battery items. A process-change notice records the intended change; it does not itself establish safety or clinical effectiveness.

FDA approval order statement

to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 3, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
N970003/S311
Regulatory pathway
PMA supplement
Product code
LWP
Decision code
OK30
Decision date
Oct 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable pulse generator, pacemaker (non-CRT).

Product code
LWP
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. N970003/S311 received

    Application receipt date recorded by FDA.

  2. N970003/S311 · FDA decision

    30-Day Notice

Related devices and submissions

Explore the linked device profile

Other records with product code LWP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
4100 Hamline Ave. N, St Paul, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records